Provexis plc Total Liabilities
Provexis plc total liabilities. Based on the latest financial reports, Provexis plc (PXS) has total liabilities worth GBX230.95K GBX (≈ $28.10 USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Provexis plc (PXS) defensive interval to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Provexis plc (2004–2025)
Total liabilities of Provexis plc from 2004 to 2025. This chart illustrates how Provexis plc's total liabilities have evolved over time, based on quarterly financial data.
Provexis plc Competitors by Total Liabilities
The table below lists competitors of Provexis plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Horizon Technology Finance Corporation
NYSE:HTFB
|
USA | $443.51 Million |
|
Cobalt Power Group Inc
V:PGP
|
Canada | CA$728.25K |
|
Atlas Corp
NASDAQ:ATCOL
|
USA | $11.96 Billion |
|
Benson Hill, Inc. Common Stock
NYSE:BHIL
|
USA | $110.70 Million |
|
Kaival Brands Innovations Group Inc
NASDAQ:KAVL
|
USA | $434.36K |
|
Atlantis Resources Ltd
LSE:SAE
|
UK | GBX97.81 Million |
|
Dianomi PLC
LSE:DNM
|
UK | GBX5.57 Million |
|
INLIF LIMITED Ordinary Shares
NASDAQ:INLF
|
USA | $8.64 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down Provexis plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see PXS total asset value.
Liquidity & Leverage Metrics
Provexis plc Total Liabilities Ratios Explained
Provexis plc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.65 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Provexis plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Provexis plc (2004–2025)
The table below shows the annual total liabilities of Provexis plc from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | GBX248.21K ≈ $30.20 |
-19.27% |
| 2024-03-31 | GBX307.45K ≈ $37.41 |
+63.24% |
| 2023-03-31 | GBX188.34K ≈ $22.92 |
+19.27% |
| 2022-03-31 | GBX157.91K ≈ $19.21 |
+4.80% |
| 2021-03-31 | GBX150.68K ≈ $18.33 |
+0.40% |
| 2020-03-31 | GBX150.08K ≈ $18.26 |
+21.87% |
| 2019-03-31 | GBX123.14K ≈ $14.98 |
+37.77% |
| 2018-03-31 | GBX89.38K ≈ $10.88 |
-32.95% |
| 2017-03-31 | GBX133.31K ≈ $16.22 |
+17.20% |
| 2016-03-31 | GBX113.75K ≈ $13.84 |
-0.29% |
| 2015-03-31 | GBX114.08K ≈ $13.88 |
+5.42% |
| 2014-03-31 | GBX108.21K ≈ $13.17 |
-95.61% |
| 2013-03-31 | GBX2.47 Million ≈ $299.92 |
+16.49% |
| 2012-03-31 | GBX2.12 Million ≈ $257.46 |
+275.18% |
| 2011-03-31 | GBX564.00K ≈ $68.62 |
+91.19% |
| 2010-03-31 | GBX295.00K ≈ $35.89 |
+26.07% |
| 2009-03-31 | GBX234.00K ≈ $28.47 |
-35.18% |
| 2008-03-31 | GBX361.00K ≈ $43.92 |
-56.97% |
| 2007-03-31 | GBX839.00K ≈ $102.08 |
+3.97% |
| 2006-03-31 | GBX807.00K ≈ $98.19 |
-14.42% |
| 2005-03-31 | GBX943.00K ≈ $114.74 |
+338.60% |
| 2004-03-31 | GBX215.00K ≈ $26.16 |
-- |
About Provexis plc
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and di… Read more